VEGFA and glioblastoma: That said, although, bevacizumab is an anti-VEGF-A antibody currently approved for recurrent glioblastoma that improves symptoms associated with increased BBB disruption [22], elective neurosurgical procedures are infrequently pursued after Avastin, given its negative impacts on wound healing [23].